Adamis Pharmaceuticals Corp·4

Jan 27, 5:52 PM ET

Adamis Pharmaceuticals Corp 4

4 · Adamis Pharmaceuticals Corp · Filed Jan 27, 2015

Insider Transaction Report

Form 4
Period: 2015-01-23
Moll Thomas
Vice President of Research
Transactions
  • Award

    Employee Stock Option (right to buy)

    2015-01-23+65,05065,050 total
    Exercise: $5.99Exp: 2025-01-23common stock (65,050 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 1/36 of the option shares on each monthly anniversary of the grant date.

Documents

1 file
  • 4
    moll-form4_012615.xmlPrimary

    OWNERSHIP DOCUMENT